Project

COVID-19 clinical research

University Medical Centre Groningen

What is it about?

At the University Medical Center in Groningen in the Netherlands, clinical research is being conducted to understand the symptoms of COVID-19 patients and to evaluate therapeutics and vaccine candidates against SARS-CoV-2, the novel coronavirus; several studies are also being conducted on people who have recovered from the infection.

Why is it important?

Millions of COVID-19 cases have been confirmed worldwide and hundreds of thousands of people have died because of the infection caused by the novel coronavirus. To develop new therapies, it is important to understand how COVID-19 evolves, the symptoms connected to the respiratory disease, as well as what happens to people who recovered from the infection.

Resources^{10 total}

Presentation

An immunotherapy against COVID-19

Prof. Toos Daemen and her team at the Department of Medical Biology are developing an immunotherapy aimed to induce T cell immunity.
Interview

Increased leptin levels increase the risk of serious corona complaints

Prof. Peter van der Voort, head of Intensive Care at the UMCG, is investigating the relationship between obesity and COVID-19.
Other

Researchers investigate corona inhaler

Researchers are investigating the possibility of administering an existing drug that may be effective against the coronavirus via an inhaler.
Interview

Developing new treatment for corona patients (in Dutch)

Dr. Bram Rutgers, internist immunologist at the UMCG, has started an experimetal treatment on patients infected with the new coronavirus.
Presentation

Preventing thrombosis in hospitalized COVID-19 patients

COVID-19 patients admitted to hospital are often immobilized, making them more prone to conditions that affect blood coagulation, such as thrombosis
Interview

What is resistance?

Internist and infectologist Douwe Postma explains what resistance is and why the virus can be deadly for some people.